From: Pubertal high fat diet: effects on mammary cancer development
qPCR dataset | Ingenuity canonical pathways | B-H-adjusted P-value | Ratio | Molecules |
---|---|---|---|---|
3Â weeks | Communication between Innate and Adaptive Immune Cells | 9.11E-03 | 2/109 | CCL3L1/CCL3L3, IL4 |
Granulocyte Adhesion and Diapedesisa | 9.33E-03a | 2/175a | CCL3L1/CCL3L3, CCL24 | |
Agranulocyte Adhesion and Diapedesisa | 9.33E-03a | 2/186a | CCL3L1/CCL3L3, CCL24 | |
4Â weeks | Human Embryonic Stem Cell Pluripotency | 1.44E-04 | 3/156 | BDNF, FZD5, LEFTY2 |
Mouse Embryonic Stem Cell Pluripotency | 4.07E-03 | 2/99 | LIF, FZD5 | |
Role of NANOG in Mammalian Embryonic Stem Cell Pluripotencya | 4.07E-03a | 2/114a | LIF, FZD5 | |
Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis | 1.20E-02 | 2/238 | TNFSF11, FZD5 | |
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritisa | 1.83E-02a | 2/332a | TNFSF11, FZD5 | |
10Â weeks | Granulocyte Adhesion and Diapedesisa | 5.66E-09a | 8/166a | IL1A, CXCR2, CCL17, CCL20, IL1B, CCL22, CCL19, CCL1 |
Agranulocyte Adhesion and Diapedesisa | 5.66E-09a | 8/176a | IL1A, CXCR2, CCL17, CCL20, IL1B, CCL22, CCL19, CCL1 | |
Hepatic Fibrosis / Hepatic Stellate Cell Activation | 1.55E-06 | 6/140 | VEGFA, IL1A, TGFB1, TGFA, IL1B, PGF | |
Altered T Cell and B Cell Signaling in Rheumatoid Arthritis | 3.24E-06 | 5/86 | IL1A, IL2, TGFB1, LTA, IL1B | |
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritisa | 3.32E-06a | 7/311a | VEGFA, IL1A, TGFB1, LTA, IL1B, IL7, PGF | |
Tumor | Molecular Mechanisms of Cancer | 7.10E-07 | 7/378 | TP53, CCND2, APAF1, BMP7, BRCA1, CTNNB1, BMP10 |
p53 Signaling | 7.10E-07 | 5/96 | TP53, CCND2, APAF1, BRCA1, CTNNB1 | |
Basal Cell Carcinoma Signaling | 1.27E-05 | 4/73 | TP53, BMP7, CTNNB1, BMP10 | |
GADD45 Signaling | 1.43E-05 | 3/22 | TP53, CCND2, BRCA1 | |
 | Role of NANOG in Mammalian Embryonic Stem Cell Pluripotencya | 4.54E-05a | 4/114a | TP53, BMP7, CTNNB1, BMP10 |